These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 26634305

  • 41. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.
    Sydora MJ, Sydora BC, Fedorak RN.
    J Crohns Colitis; 2012 Mar; 6(2):207-14. PubMed ID: 22325175
    [Abstract] [Full Text] [Related]

  • 42. Evaluation of the Quantum Blue® rapid test for faecal calprotectin.
    Wassell J, Wallage M, Brewer E.
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):55-8. PubMed ID: 21930735
    [Abstract] [Full Text] [Related]

  • 43. A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease.
    Naismith GD, Smith LA, Barry SJ, Munro JI, Laird S, Rankin K, Morris AJ, Winter JW, Gaya DR.
    Aliment Pharmacol Ther; 2013 Mar; 37(6):613-21. PubMed ID: 23347334
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [Faecal calprotectin in inflammatory bowel disease].
    Sipponen T, Kolho KL.
    Duodecim; 2011 Mar; 127(24):2631-7. PubMed ID: 22320105
    [Abstract] [Full Text] [Related]

  • 46. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease.
    De Sloovere MMW, De Smet D, Baert FJ, Debrabandere J, Vanpoucke HJM.
    Clin Chem Lab Med; 2017 Aug 28; 55(9):1435-1446. PubMed ID: 28076305
    [Abstract] [Full Text] [Related]

  • 47. Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50 years.
    Kennedy NA, Clark A, Walkden A, Chang JC, Fascí-Spurio F, Muscat M, Gordon BW, Kingstone K, Satsangi J, Arnott ID, Lees CW.
    J Crohns Colitis; 2015 Jan 28; 9(1):41-9. PubMed ID: 25135754
    [Abstract] [Full Text] [Related]

  • 48. The semi-quantitative calprotectin rapid test--is it useful in inflammatory bowel disease?
    Dranga M, Dumitrescu G, Badea M, Blaj A, Mihai C, Prelipcean CC.
    Rev Med Chir Soc Med Nat Iasi; 2012 Jan 28; 116(3):761-5. PubMed ID: 23272524
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D.
    Gut; 2007 Dec 28; 56(12):1706-13. PubMed ID: 17675327
    [Abstract] [Full Text] [Related]

  • 51. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
    Klingberg E, Strid H, Ståhl A, Deminger A, Carlsten H, Öhman L, Forsblad-d'Elia H.
    Arthritis Res Ther; 2017 Feb 02; 19(1):21. PubMed ID: 28148281
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Faecal calprotectin in the diagnosis of inflammatory bowel disease.
    Burri E, Beglinger C.
    Biochem Med (Zagreb); 2011 Feb 02; 21(3):245-53. PubMed ID: 22420238
    [Abstract] [Full Text] [Related]

  • 54. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T, Benguş A, Dinu R, Voiosu AM, Bălănescu P, Băicuş C, Diculescu M, Voiosu R, Mateescu B.
    J Gastrointestin Liver Dis; 2014 Sep 02; 23(3):273-8. PubMed ID: 25267955
    [Abstract] [Full Text] [Related]

  • 55. [Faecal calprotectin in inflammatory bowel diseases: review].
    Kallel L, Fekih M, Boubaker J, Filali A.
    Tunis Med; 2011 May 02; 89(5):425-9. PubMed ID: 21557177
    [Abstract] [Full Text] [Related]

  • 56. The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel disease.
    Kwapisz L, Gregor J, Chande N, Yan B, Ponich T, Mosli M.
    Scand J Gastroenterol; 2017 Aug 02; 52(8):846-850. PubMed ID: 28423962
    [Abstract] [Full Text] [Related]

  • 57. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease.
    Reinders CA, Jonkers D, Janson EA, Stockbrügger RW, Stobberingh EE, Hellström PM, Lundberg JO.
    Scand J Gastroenterol; 2007 Oct 02; 42(10):1151-7. PubMed ID: 17852876
    [Abstract] [Full Text] [Related]

  • 58. Faecal calprotectin in children with clinically quiescent inflammatory bowel disease.
    Sipponen T, Kolho KL.
    Scand J Gastroenterol; 2010 Aug 02; 45(7-8):872-7. PubMed ID: 20377469
    [Abstract] [Full Text] [Related]

  • 59. Assessing the Correlation of Fecal Calprotectin and the Clinical Disease Activity Index in Patients With Ulcerative Colitis.
    Amiriani T, Besharat S, Dadjou M, Roshandel G, Mirkarimi H, Salamat F, Joshaghani H.
    Gastroenterol Nurs; 2018 Aug 02; 41(3):201-205. PubMed ID: 29847394
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.